Spectrum Pharmaceuticals is a leading biotechnology company with a focus in Oncology and Hematology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.
Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System.
Ticker Symbol: SPPI
August 9, 2016SPI-2012 (eflapegrastim) pivotal Phase 3 study is actively enrolling breast cancer patien
August 2, 2016HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnolo